CELLCEUTIX Stock OTC Bulletin Board
Equities
CTIX
US15115V1017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Feb. 01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
Financials (USD)
Sales 2022 | 0.02 | Sales 2023 | - | Capitalization | 10.37M |
---|---|---|---|---|---|
Net income 2022 | -7M | Net income 2023 | -3M | EV / Sales 2022 | 673,326,722 x |
Net cash position 2022 | 2.52M | Net cash position 2023 | 793K | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.22
x | P/E ratio 2023 |
-3.19
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.87% |
Managers | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 07-06-19 |
Jane Harness
CTO | Chief Tech/Sci/R&D Officer | 55 | 16-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 07-06-19 |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 104B | |
+7.06% | 97.47B | |
+5.71% | 22.25B | |
-12.66% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.35% | 16.36B | |
+7.36% | 14.39B | |
+37.40% | 12.37B |
- Stock Market
- Equities
- IPIX Stock
- CTIX Stock